Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 12
Phase 22

Trial Status

Completed1
Terminated2

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT02028988Phase 2Completed
Enzalutamide + External Beam Rt For Prostate
Intermediate Risk Prostate Cancer
PrincipalinvestigatorStart date: 2014-02-01
NCT00953576Phase 1/2Terminated
Ketoconazole, Hydrocortisone, Dutasteride and Lapatinib (KHAD-L) in Prostate Cancer
Prostate Cancer
PrincipalinvestigatorStart date: 2009-09-29
NCT01741753Phase 1Terminated
BKM120+Abiraterone Acetate for Metastatic CRPC
Prostate Cancer
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Beth Israel Deaconess Medical Center

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT02028988Phase 2PrincipalInvestigator

Enzalutamide + External Beam Rt For Prostate

Intermediate Risk Prostate Cancer
Completed
NCT00953576Phase 1/2PrincipalInvestigator

Ketoconazole, Hydrocortisone, Dutasteride and Lapatinib (KHAD-L) in Prostate Cancer

Prostate Cancer
Terminated
NCT01741753Phase 1PrincipalInvestigator

BKM120+Abiraterone Acetate for Metastatic CRPC

Prostate Cancer
Terminated

All 3 trials loaded